In This Section
2022 SNMMI and SNMMI-TS Grants and Awards Recipients
2022 Grants and Awards Recipients (funded by the ERF)
Sam Gambhir, MD Trailblazer Award - Andrei Iagaru, MD, FACNM
Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety - Carlos Uribe-Munoz, PhD
Michael J. Welch Award - Weibo Cai, PhD, FAIMBE, FSNMMI
Michael J. Welch Postdoctoral Grant - Jay Wright, PhD
Mitzi & William Blahd, MD, Pilot Research Grant - Tahir Yusufaly, PhD
Robert E. Henkin, MD, Government Relations Fellowship - Angela Weiler, CNMT
ERF SNMMI Molecular Imaging Research Grant for Junior Academic Faculty - n/a 2022
ERF SNMMI Postdoctoral Molecular Imaging Scholar Program - n/a 2022
SNMMI CMIIT Laboratory Professional Recognition Award for Contributions to Molecular Imaging - Teja Kalidindi, BS, MS
Bradley-Alavi Student Fellowships: Vibha Balaji and Abhijit Bhattaru
Paul C. Aebersold, PhD Award - Robert Mach, PhD
2022 Alavi-Mandell Awards Published in 2021 -
Preclinical Development of F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis
Hazem Ahmed, Rahel Wallimann, Ahmed Haider, Vahid Hosseini, Stefan Gruber, Marvin Robledo, Thi A.N. Nguyen, Adrienne Müller Herde, Irina Iten, Claudia Keller, Viola Vogel, Roger Schibli, Bernhard Wünsch, Linjing Mu, and Simon M. Ametamey
Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
J Nucl Med 2021; 62:259–265
Transarterial Radioembolization Versus Systemic Treatment for Hepatocellular Carcinoma with Macrovascular Invasion: Analysis of the U.S. National Cancer Database
Joseph C. Ahn, Marie Lauzon, Michael Luu, Marc L. Friedman, Kambiz Kosari , Nicholas Nissen, Shelly C. Lu, Lewis R. Roberts, Amit G. Singal, and Ju Dong Yang
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
J Nucl Med 2021; 62:57–58
Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger, and Ali Afshar-Oromieh
Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
J Nucl Med 2021; 62:1252–1257
Dose–Response and Dose–Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer
Ahmed A. Alsultan, Caren van Roekel, Maarten W. Barentsz, Maarten L.J. Smits, Britt Kunnen, Miriam Koopman, Arthur J.A.T. Braat, Rutger C.G. Bruijnen, Bart de Keizer, and Marnix G.E.H. Lam
Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
J Nucl Med 2021; 62:1616–1623
Cyclotron-Produced 132La as a PET Imaging Surrogate for Therapeutic 225Ac
Eduardo Aluicio-Sarduy, Todd E. Barnhart, Jamey Weichert, Reinier Hernandez, and Jonathan W. Engle
Department of Medical Physics, University of Wisconsin–Madison, Madison, Wisconsin
J Nucl Med 2021; 62:1012–1015
The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin, and Jeremie Calais
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California
J Nucl Med 2021; 62:1244–1251
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen, and Matthias N. van Oosterom
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
J Nucl Med 2021; 62:1314–1317
GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients
Ingrid L. Bakker, Alida C. Fröberg, Martijn B. Busstra, J. Fred Verzijlbergen, Mark Konijnenberg, Geert J.L.H. van Leenders, Ivo G. Schoots, Erik de Blois, Wytske M. van Weerden, Simone U. Dalm, Theodosia Maina, Berthold A. Nock, and Marion de Jong
Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands
J Nucl Med 2021; 62:1517–1523
PET/MRI Improves Management of Children with Cancer
Lucia Baratto, K. Elizabeth Hawk, Lisa States, Jing Qi, Sergios Gatidis, Louise Kiru, and Heike E. Daldrup-Link
Department of Radiology, Stanford University, Stanford, California
J Nucl Med 2021; 62:1334–1340
Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
Danique M.S. Berger, Nynke S. van den Berg, Vincent van der Noort, Bernies van der Hiel, Renato A. Valdés Olmos, Tessa A. Buckle, Gijs H. KleinJan, Oscar R. Brouwer, Lenka Vermeeren, Baris Karakullukçu, Michiel W.M. van den Brekel, Bart A. van de Wiel, Omgo E. Nieweg, Alfons J.M. Balm, Fijs W.B. van Leeuwen, and W. Martin C. Klop
Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute–Antoni van Leeuwenhoek, Amsterdam, The Netherlands
J Nucl Med 2021; 62:1357–1362
Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
Ganna Blazhenets, Lars Frings, Arnd Sörensen, and Philipp T. Meyer, for the Alzheimer’s Disease Neuroimaging Initiative
Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
J Nucl Med 2021; 62:855–860
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Ganna Blazhenets, Nils Schroeter, Tobias Bormann, Johannes Thurow, Dirk Wagner, Lars Frings, Cornelius Weiller, Philipp T. Meyer, Andrea Dressing, and Jonas A. Hosp
Department of Nuclear Medicine, Faculty of Medicine, Medical Center–University of Freiburg, University of Freiburg, Freiburg, Germany
J Nucl Med 2021; 62:910–915
SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard, and Daniela E. Oprea-Lager
Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands
J Nucl Med 2021; 62:1264–1269
Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers, and Carolina P. Schröder
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2021; 62:1214–1220
Repurposing 11C-PS13 for PET Imaging of Cyclooxygenase-1 in Ovarian Cancer Xenograft Mouse Models
Amanda J. Boyle, Junchao Tong, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis, and Neil Vasdev
Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
J Nucl Med 2021; 62:665–668
Deep-Learning 18F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma
Nicolò Capobianco, Michel Meignan, Anne-Ségolène Cottereau, Laetitia Vercellino, Ludovic Sibille, Bruce Spottiswoode, Sven Zuehlsdorff, Olivier Casasnovas, Catherine Thieblemont, and Irène Buvat
Siemens Healthcare GmbH, Erlangen, Germany
J Nucl Med 2021; 62:30–36
Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, Andreas Pfeifer, Peter Oturai, Seppo W. Langer, Ulrich Knigge, Claes Nøhr Ladefoged, and Andreas Kjaer
Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
J Nucl Med 2021; 62:1564–1570
Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms
Lukas M. Carter, Chansoo Choi, Simone Krebs, Bradley J. Beattie, Chan Hyeong Kim, Heiko Schoder, Wesley E. Bolch, and Adam L. Kesner
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2021; 62:1805–1814
Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon, and Hyewon Hyun
Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University/Rhode Island Hospital, Providence, Rhode Island
J Nucl Med 2021; 62:1207–1213
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study
Lin Cheng, Ri Sa, Qiong Luo, Hao Fu, Yuchen Jin, Linglin Tang, Yi Yang, Chunjing Yu, and Libo Chen
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
J Nucl Med 2021; 62:62–68
Evaluation of 18F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb Perfusion
Michal Chodyla, Aydin Demircioglu, Benedikt M. Schaarschmidt, Stefanie Bertram, Nils Martin Bruckmann, Jennifer Haferkamp, Yan Li, Sebastian Bauer, Lars Podleska, Christoph Rischpler, Michael Forsting, Ken Herrmann, Lale Umutlu, and Johannes Grueneisen
Department of Diagnostic and Interventional Radiology, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
J Nucl Med 2021; 62:348–353
18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial
Tine Nøhr Christensen, Seppo W. Langer, Gitte Persson, Klaus Richter Larsen, Annika Loft, Annemarie Gjelstrup Amtoft, Anne Kiil Berthelsen, Helle Hjorth Johannesen, Sune Høgild Keller, Andreas Kjaer, and Barbara Malene Fischer
Department of Clinical Physiology, Nuclear Medicine, and PET, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
J Nucl Med 2021; 62:628–635
Mapping Arginase Expression with 18F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids
Gonçalo S. Clemente, Inês F. Antunes, Santosh Kurhade, Mariska P.M. van den Berg, Jürgen W.A. Sijbesma, Aren van Waarde, Rogier C. Buijsman, Nicole Willemsen-Seegers, Reinoud Gosens, Herman Meurs, Alexander Dömling, and Philip H. Elsinga
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2021; 62:1163–1170
Clinical Utility of 18F-FDG PET/CT for Staging and Treatment Planning in Urachal Adenocarcinoma
Jeeban P. Das, Hebert A. Vargas, Soleen Ghafoor, Alvin C. Goh, and Gary A. Ulaner
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2021; 62:643–647
PARP1: A Potential Molecular Marker to Identify Cancer During Colposcopy Procedures
Paula Demétrio de Souza França, Navjot Guru, Abigail R. Kostolansky, Audrey Mauguen, Giacomo Pirovano, Susanne Kossatz, Sheryl Roberts, Marcio Abrahão, Snehal G. Patel, Kay J. Park, Thomas Reiner, and Elizabeth Jewell
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2021; 62:941–948
A Novel Time–Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE
Theresa P. Devasia, Yuni K. Dewaraja, Kirk A. Frey, Ka Kit Wong, and Matthew J. Schipper
Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
J Nucl Med 2021; 62:1118–1125
A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy
Sander C. Ebbers, Maarten W. Barentsz, Bart de Keizer, Gerard C. Krijger, Marnix G.E.H. Lam, and Arthur J.A.T. Braat
Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands
J Nucl Med 2021; 62:816–822
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
Andrea Farolfi, Nader Hirmas, Andrei Gafita, Manuel Weber, Francesco Barbato, Axel Wetter, Riccardo Mei, Davide Pianori, Boris Hadaschik, Ken Herrmann, Paolo Castellucci, Stefano Fanti, Matthias Eiber, and Wolfgang P. Fendler
Nuclear Medicine Unit, University of Bologna, S. Orsola Hospital, Bologna, Italy
J Nucl Med 2021; 62:675–678
Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma
Justin Ferdinandus, Francesco Barbato, Michal Chodyla, Wolfgang P. Fendler, Lukas Kessler, Kelsey L. Pomykala, Martin Metzenmacher, Frederik Krefting, Thomas Hager, Lale Umutlu, Ken Herrmann, and Daniel C. Christoph
Department of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium–University Hospital Essen, Essen, Germany
J Nucl Med 2021; 62:191–194
Preclinical Characterization of the Radioimmunoconjugate 111In or 90Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate
Yuichi Funase, Eri Nakamura, Masamichi Kajita, Yasutaka Saito, Shinobu Oshikiri, Michi Kitano, Masahiko Tokura, Akihiro Hino, and Tomoya Uehara
RI Research Department, Fujifilm Toyama Chemical Co., Ltd., Chiba, Japan
J Nucl Med 2021; 62:232–239
18F-FDG PET/CT Sheds Light on a Case of Hyponatremia
Delphine Gans, Pauline Braet, Niloefar Ahmadi Bidakhvidi, Christophe M. Deroose, Brigitte Decallonne, and Sander Jentjens
Division of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium
J Nucl Med 2021; 62:1653–1654
Latest Advances in Imaging Oxidative Stress in Cancer
Hannah E. Greenwood and Timothy H. Witney
School of Biomedical Engineering and Imaging Sciences, King’s College London, London, United Kingdom
J Nucl Med 2021; 62:1506–1510
Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy
Patrycja Guzik, Hsin-Yu Fang, Luisa M. Deberle, Martina Benešová, Susan Cohrs, Silvan D. Boss, Simon M. Ametamey, Roger Schibli, and Cristina Müller
Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen-PSI, Switzerland
J Nucl Med 2021; 62:1475–1481
Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury
Joseph Haddad, Joseph D. Latoche, Shubhanchi Nigam, Michael C. Bellavia, Kathryn E. Day, Qin Zhu, W. Barry Edwards, Carolyn J. Anderson, and Sina Tavakoli
Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania
J Nucl Med 2021; 62:280–286
One-Stop Shop: 18F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases
Jochen Hammes, Gérard N. Bischof, Karl P. Bohn, Özgür Onur, Anja Schneider, Klaus Fliessbach, Merle C Hönig, Frank Jessen, Bernd Neumaier, Alexander Drzezga, and Thilo van Eimeren
Multimodal Neuroimaging, Department of Nuclear Medicine, University Hospital and Medical Faculty, University of Cologne, Cologne, Germany
J Nucl Med 2021; 62:240–246
The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study
Sara Harsini, Heather Saprunoff, Tina Alden, Behnoud Mohammadi, Don Wilson, and François Bénard
BC Cancer, Vancouver, British Columbia, Canada
J Nucl Med 2021; 62:81–87
Bone Mineral Density: Clinical Relevance and Quantitative Assessment
Katherine N. Haseltine, Tariq Chukir, Pinar J. Smith, Justin T. Jacob, John P. Bilezikian, and Azeez Farooki
Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2021; 62:446–454
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer
Kelly E. Henry, Travis M. Shaffer, Kyeara N. Mack, Janine Ring, Anuja Ogirala, Susanne Klein-Scory, Christina Eilert-Micus, Wolff Schmiegel, Thilo Bracht, Barbara Sitek, Marguerite Clyne, Colm J. Reid, Bence Sipos, Jason S. Lewis, Holger Kalthoff, and Jan Grimm
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2021; 62:1384–1390
Targeted PET Imaging of Chemokine Receptor 2–Positive Monocytes and Macrophages in the Injured Heart
Gyu Seong Heo, Geetika Bajpai, Wenjun Li, Hannah P. Luehmann, Deborah H. Sultan, Hao Dun, Florian Leuschner, Steven L. Brody, Robert J. Gropler, Daniel Kreisel, Kory J. Lavine, and Yongjian Liu
Department of Radiology, Washington University School of Medicine, St. Louis, Missouri
J Nucl Med 2021; 62:111–114
The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease
Gyu Seong Heo, Lanlan Lou, Deborah Sultan, and Yongjian Liu
Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri
J Nucl Med 2021; 62:1341–1346
68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber, and Wolfgang P. Fendler
Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany
J Nucl Med 2021; 62:1235–1241
Radionuclide Imaging of the Gut–Brain Axis in Parkinson Disease
Jacob Horsager, Karoline Knudsen, and Per Borghammer
Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark
J Nucl Med 2021; 62:1504-1505
The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with (±)-11C-YJH08 PET
Yangjie Huang, Ning Zhao, Yung-hua Wang, Charles Truillet, Junnian Wei, Matthew F.L. Parker, Joseph E. Blecha, Christopher R. Drake, Henry F. VanBrocklin, Diego Garrido-Ruiz, Matthew P. Jacobson, Rahul Aggarwal, Spencer C. Behr, Robert R. Flavell, David M. Wilson, Youngho Seo, and Michael J. Evans
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
J Nucl Med 2021; 62:723–731
Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
Vilma I.J. Jallinoja and Jacob L. Houghton
Department of Radiology, Stony Brook University, Stony Brook, New York
J Nucl Med 2021; 62:1200–1206
89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho, and Kyung-Han Lee
Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea
J Nucl Med 2021; 62:656–664
First Experience Using 18F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma
Lukas Kessler, Anna M. Schlitter, Markus Krönke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon Robinson, Cesare Orlandi, Michael Herz, Behrooz H. Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber, and Christoph Rischpler
Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
Søren Klingenberg, Mads R. Jochumsen, Benedicte P. Ulhøi, Jacob Fredsøe, Karina D. Sørensen, Michael Borre, and Kirsten Bouchelouche
Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark
J Nucl Med 2021; 62:214–220
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
Dejan Kostyszyn, Tobias Fechter, Nico Bartl, Anca L. Grosu, Christian Gratzke, August Sigle, Michael Mix, Juri Ruf, Thomas F. Fassbender, Selina Kiefer, Alisa S. Bettermann, Nils H. Nicolay, Simon Spohn, Maria U. Kramer, Peter Bronsert, Hongqian Guo, Xuefeng Qiu, Feng Wang, Christoph Henkenberens, Rudolf A. Werner, Dimos Baltas, Philipp T. Meyer, Thorsten Derlin, Mengxia Chena, and Constantinos Zamboglou
Division of Medical Physics, Department of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
J Nucl Med 2021; 62:823–828
A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients
Oana C. Kulterer, Sarah Pfaff, Wolfgang Wadsak, Nathalie Garstka, Mesut Remzi, Chrysoula Vraka, Lukas Nics, Markus Mitterhauser, Franziska Bootz, Samuele Cazzamalli, Nikolaus Krall, Dario Neri, and Alexander R. Haug
Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
J Nucl Med 2021; 62:360–365
Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation
Manoj Kumar, Kelley Salem, Justin J. Jeffery, Yongjun Yan, Aparna M. Mahajan, and Amy M. Fowler
Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
J Nucl Med 2021; 62:500–506
177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F. Uribe, Helen Merkens, Chengcheng Zhang, and François Bénard
Department of Molecular Oncology, BC Cancer, Vancouver, British Columbia, Canada
J Nucl Med 2021; 62:521–527
Simulation of Low-Dose Protocols for Myocardial Perfusion 82Rb Imaging
Martin Lyngby Lassen, Yuka Otaki, Paul Kavanagh, Robert J.H. Miller, Daniel S. Berman, and Piotr J. Slomka
Department of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, California
J Nucl Med 2021; 62:1112–1117
Nondisplaceable Binding Is a Potential Confounding Factor in 11C-PBR28 Translocator Protein PET Studies
Gjertrud L. Laurell, Pontus Plavén-Sigray, Aurelija Jucaite, Andrea Varrone, Kelly P. Cosgrove, Claus Svarer, Gitte M. Knudsen, Karolinska Schizophrenia Project Consortium, R. Todd Ogden, Francesca Zanderigo, Simon Cervenka, Ansel T. Hillmer, and Martin Schain
Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
J Nucl Med 2021; 62:412–417
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of 177Lu-DOTA-EB-TATE
Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Chengy, Zhaohui Zhuy, and Xiaoyuan Cheny
Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
J Nucl Med 2021; 62:386–392
64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
Mathias Loft, Esben A. Carlsen, Camilla B. Johnbeck, Helle H. Johannesen, Tina Binderup, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne K. Berthelsen, Seppo W. Langer, Ulrich Knigge, and Andreas Kjaer
Department of Clinical Physiology, Nuclear Medicine, and PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
J Nucl Med 2021; 62:73–80
Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets
Shaun Loveless, Jose R. Blanco, George L. Diehl III, Rawdah T. Elbahrawi, Tommaso S. Carzaniga, Saverio Braccini, and Suzanne E. Lapi
Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
J Nucl Med 2021; 62:131–136
Imaging Immunometabolism in Atherosclerosis
Philip Z. Mannes and Sina Tavakoli
Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania
J Nucl Med 2021; 62:896–902
Repurposing 99mTc-Mebrofenin as a Probe for Molecular Imaging of Hepatocyte Transporters
Solène Marie, Irene Hernández-Lozano, Oliver Langer, and Nicolas Tournier
Laboratoire d’Imagerie Biomédicale Multimodale, BioMaps, Université Paris-Saclay, CEA, CNRS, INSERM, Service Hospitalier Frédéric Joliot, Orsay, France
J Nucl Med 2021; 62:1043–1047
Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
Pegah Masrori, Donatienne Van Weehaeghe, Koen Van Laere, and Philip Van Damme
Neuromuscular Reference Centre, Department of Neurology, University Hospitals Leuven, Leuven, Belgium
J Nucl Med 2021; 62:1318–1319
Diagnostic Value, Oncologic Outcomes, and Safety Profile of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy for Prostate Cancer
Elio Mazzone, Paolo Dell’Oglio, Nikos Grivas, Esther Wit, Maarten Donswijk, Alberto Briganti, Fijs Van Leeuwen, and Henk van der Poel
Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
J Nucl Med 2021; 62:1363–1371
Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging
Dennie Meijer, Maarten L. Donswijk, Yves J.L. Bodar, Pim J. van Leeuwen, Henk G. van der Poel, Wouter V. Vogel, Jakko A. Nieuwenhuijzen, N. Harry Hendrikse, Daniela E. Oprea-Lager, and André N. Vis
Department of Urology, Amsterdam University Medical Center, VU University, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands
J Nucl Med 2021; 62:961–967
Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brüggemann, Philipp T. Meyer, Cordula A. Jilg, and Juri Ruf
Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany
J Nucl Med 2021; 62:1741–1746
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively, and Flavia Pichiorri
Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California
J Nucl Med 2021; 62:795–801
TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody
Megan Minnix, Lin Li, Paul J. Yazaki, Aaron D. Miller, Junie Chea, Erasmus Poku, An Liu, Jeffrey Y.C. Wong, Russell C. Rockne, David Colcher, and John E. Shively
Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California
J Nucl Med 2021; 62:55–61
Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the
Reference Standard
Janna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, Tim Ullrich, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Lena Häberle, Marc Ingenwerth, Lale Umutlu, Wolfgang Peter Fendler, Tanja Fehm, Ken Herrmann, Gerald Antoch, Lino Morris Sawicki, and Julian Kirchner
Department of Diagnostic and Interventional Radiology, University of Dusseldorf, Dusseldorf, Germany
J Nucl Med 2021; 62:1677–1683
Prognostic Value of Bone Marrow Metabolism on Pretreatment 18F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
Ryusuke Nakamoto, Lisa C. Zaba, Tie Liang, Sunil Arani Reddy, Guido Davidzon, Carina Mari Aparici, Judy Nguyen, Farshad Moradi, Andrei Iagaru, and Benjamin Lewis Franc
Department of Radiology, Stanford University, Stanford, California
J Nucl Med 2021; 62:1380–1383
A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model
Lucas Narciso, Tracy Ssali, Linshan Liu, Heather Biernaski, John Butler, Laura Morrison, Jennifer Hadway, Jeffrey Corsaut, Justin W. Hicks, Michael C. Langham, Felix W. Wehrli, Hidehiro Iida, and Keith St Lawrence
Lawson Health Research Institute, London, Ontario, Canada
J Nucl Med 2021; 62:1789–1796
Repeatability of Radiomic Features of Brown Adipose Tissue
Aria Nazeri, John P. Crandall, Tyler J. Fraum, and Richard L. Wahl
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
J Nucl Med 2021; 62:700–706
Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial
Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso, and Andreas Kjaer
Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
J Nucl Med 2021; 62:354–359
Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE
Claudia Ortega, Rebecca K.S. Wong, Josh Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Amy Liu, and Ur Metser
Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada
J Nucl Med 2021; 62:1406–1414
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis, and Freddy E. Escorcia
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2021; 62:366–371
Molecular Imaging: PARP-1 and Beyond
Laura N. Puentes, Mehran Makvandi, and Robert H. Mach
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
J Nucl Med 2021; 62:765–770
Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
Sheryl Roberts, Eshita Khera, Crystal Choi, Tejas Navaratna, Jan Grimm, Greg M. Thurber, and Thomas Reiner
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2021; 62:839–848
Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang, and Stefan A. Koerber
Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
J Nucl Med 2021; 62:779–786
Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography
Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Fang-Cheng Yeh, Nicholas D’Cruz, Prabesh Kanel, and Martijn L.T.M. Müller
Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan
J Nucl Med 2021; 62:545–552
Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah, and Martin Gotthardt
Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands
J Nucl Med 2021; 62:1258–1263
Minimal Extrathyroidal Extension in Papillary Thyroid Microcarcinoma Is an Independent Risk Factor for Relapse Through Lymph Node and Distant Metastases
Robert Seifert, Michael Schäfers, Barbara Heitplatz, Laura Kerschke, Burkhard Riemann, and Benjamin Noto
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
J Nucl Med 2021; 62:1702–1709
Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial
Pieter J. Steinkamp, Bobby K. Pranger, Mei-Fang Li, Matthijs D. Linssen, Floris J. Voskuil, Lukas B. Been, Barbara L. van Leeuwen, Albert J.H. Suurmeijer, Wouter B. Nagengast, Schelto Kruijff, Robert J. van Ginkel, and Gooitzen M. van Dam
Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2021; 62:342–347
Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell Engager Molecule Shows Specific Tumor Uptake and Distributes to Mesothelin and CD3-Expressing Tissues
Frans V. Suurs, Grit Lorenczewski, Julie M. Bailis, Sabine Stienen, Matthias Friedrich, Fei Lee, Bert van der Vegt, Elisabeth G.E. de Vries, Derk Jan A. de Groot, and Marjolijn N. Lub-de Hooge
Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands
J Nucl Med 2021; 62:1797–1804
Relationship Between Tau and Cognition in the Evolution of Alzheimer’s Disease: New Insights from Tau PET
Jeremy A. Tanner and Gil D. Rabinovici
Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California
J Nucl Med 2021; 62:612–613
Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes
Hiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, Talia C. Oughourlian, Issei Ueda, Hiroyuki Uetani, Catalina Raymond, Albert Lai, Timothy F. Cloughesy, Phioanh L. Nghiemphu, Linda M. Liau, Whitney B. Pope, Noriko Salamon, and Benjamin M. Ellingson
UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California
J Nucl Med 2021; 62:319–325
Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging
Joseph Therriault, Andrea L. Benedet, Tharick A. Pascoal, Melissa Savard, Nicholas J. Ashton, Mira Chamoun, Cecile Tissot, Firoza Lussier, Min Su Kang, Gleb Bezgin, Tina Wang, Jaime Fernandes-Arias, Gassan Massarweh, Paolo Vitali, Henrik Zetterberg, Kaj Blennow, Paramita Saha-Chaudhuri, Jean-Paul Soucy, Serge Gauthier, and Pedro Rosa-Neto
Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
J Nucl Med 2021; 62:247–252
Liver Enzyme Elevation After 177Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer
Hannes Treiber, Alexander König, Albrecht Neesse, Annika Richter, Carsten Oliver Sahlmann, and Arne Strauss
Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
J Nucl Med 2021; 62:1016–1019
Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy
Maria J. Valkema, Berend J. van der Wilk, Ben M. Eyck, Bas P.L. Wijnhoven, Manon C.W. Spaander, Michail Doukas, Sjoerd M. Lagarde, Wendy M.J. Schreurs, Mark J. Roef, J. Jan B. van Lanschot, and Roelf Valkema
Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
J Nucl Med 2021; 62:486–492
Assessment of Bone Lesions with 18F-FDG PET Compared with 99mTc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management
Suzanne C. van Es, Ton Velleman, Sjoerd G. Elias, Frederike Bensch, Adrienne H. Brouwers, Andor W.J.M. Glaudemans, Thomas C. Kwee, Marleen Woltman-van Iersel, John H. Maduro, Sjoukje F. Oosting, Elisabeth G.E. de Vries, and Carolina P. Schröder
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2021; 62:177–183
A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes
Mathew Veal, Gemma Dias, Veerle Kersemans, Deborah Sneddon, Stephen Faulkner, and Bart Cornelissen
Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
J Nucl Med 2021; 62:1537–1544
First-in-Humans Study of 68Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
Riikka Viitanen, Olli Moisio, Petteri Lankinen, Xiang-Guo Li, Mikko Koivumäki, Sami Suilamo, Tuula Tolvanen, Kirsi Taimen, Markku Mali, Ia Kohonen, Ilpo Koskivirta, Vesa Oikonen, Helena Virtanen, Kristiina Santalahti, Anu Autio, Antti Saraste, Laura Piril, Pirjo Nuutila, Juhani Knuuti, Sirpa Jalkanen, and Anne Roivainen
Turku PET Centre, University of Turku, Turku, Finland
J Nucl Med 2021; 62:577–583
Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism
Varsha Viswanath, Rong Zhou, Hsiaoju Lee, Shihong Li, Abigail Cragin, Robert K. Doot, David A. Mankoff, and Austin R. Pantel
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
J Nucl Med 2021; 62:1154–1162
Metallofluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI
Chao Wang, Benjamin I. Leach, Deanne Lister, Stephen R. Adams, Hongyan Xu, Carl Hoh, Patrick McConville, Jing Zhang, Karen Messer, and Eric T. Ahrens
Department of Radiology, University of California San Diego, La Jolla, California
J Nucl Med 2021; 62:1146–1153
PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
Manuel Weber, Claudia Kurek, Francesco Barbato, Matthias Eiber, Tobias Maurer, Michael Nader, Boris Hadaschik, Viktor Grünwald, Ken Herrmann, Axel Wetter, and Wolfgang P. Fendler
Department of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium–University Hospital Essen, Essen, Germany
J Nucl Med 2021; 62:88–91
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard, and Thorvardur R. Halfdanarson
Mayo Clinic, Rochester, Minnesota
J Nucl Med 2021; 62:1320
Lymph Node Staging with a Combined Protocol of 18F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical Carcinoma
Matthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, Stefan Kommoss, Konstantin Nikolaou, Samine Sahbai, Christian la Fougère, Sara Yvonne Brucker, and Helmut Dittmann
Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany
J Nucl Med 2021; 62:1062–1067
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Rudolf A. Werner, Thorsten Derlin, Steven P. Rowe, Lena Bundschuh, Gabriel T. Sheikh, Martin G. Pomper, Sebastian Schulz, Takahiro Higuchi, Andreas K. Buck, Frank M. Bengel, Ralph A. Bundschuh, and Constantin Lapa
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany
J Nucl Med 2021; 62:514–520
Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh, and Thomas A. Hope
Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California
J Nucl Med 2021; 62:1285–1291
Direct Attenuation Correction Using Deep Learning for Cardiac SPECT: A Feasibility Study
Jaewon Yang, Luyao Shi, Rui Wang, Edward J. Miller, Albert J. Sinusas, Chi Liu, Grant T. Gullberg, and Youngho Seo
Physics Research Laboratory, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
J Nucl Med 2021; 62:1645–1652
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients
Mathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, and Harun Ilhan
Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
J Nucl Med 2021; 62:669–674
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
Ning Zhao, Yangjie Huang, Yung-hua Wang, Ryan K. Muir, Ying-Chu Chen, Junnian Wei, Nima Hooshdaran, Pavithra Viswanath, Youngho Seo, Davide Ruggero, Adam R. Renslo, and Michael J. Evans
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
J Nucl Med 2021; 62:949–955
Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky, and Ganesan Vaidyanathan
Department of Radiology, Duke University Medical Center, Durham, North Carolina
J Nucl Med 2021; 62:1624–1630
SNMMI JNM Best Paper Awards -
Editors’ Choice Award
FOR THE BEST CLINICAL ARTICLE IN 2021
is presented to
Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang, and Stefan A. Koerber
Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
for
Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
J Nucl Med. 2021; 62:779–786
The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE BEST BASIC SCIENCE ARTICLE IN 2021
is presented to
Mark G. MacAskill, Agne Stadulyte, Lewis Williams, Timaeus E.F. Morgan, Nikki L. Sloan, Carlos J. Alcaide-Corral, Tashfeen Walton, Catriona Wimberley, Chris-Anne McKenzie, Nick Spath, William Mungall, Ralph BouHaidar, Marc R. Dweck, Gillian A. Gray, David E. Newby, Christophe Lucatelli, Andrew Sutherland, Sally L. Pimlott, and Adriana A.S. Tavares
University/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
for
Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
J Nucl Med. 2021; 62:536–544
The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE OVERALL BEST ARTICLE IN 2021
is presented to
Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang, and Stefan A. Koerber
Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
for
Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
J Nucl Med. 2021; 62:779–786
Susan C. Weiss Clinical Advancement Scholarship - n/a 2022
ERF-SNMMI-TS Bachelor's or Master's Degree Completion Scholarship - Angela Weiler, CNMT and Diane Soulek, CNMT
ERF-SNMMI-TS Advanced Degree Scholarship - Sarah Frye, CNMT
Paul Cole Student Technologist Scholarship - Fernando Anleu, Dylan Cooper, Rebecca Covey, Allison Knuth, Ashley LaGrone, Mikaya Rodgers, Bridget Russell, Bryn Schlender, Marina Steele, Teagan White
ERF-SNMMI-TS Outstanding Technologist -
Kathy Thompson Hunt Outstanding Educator Award -
ERF-SNMMI-TS JNMT Best Paper Awards -
Editors’ Choice Award
FOR 1ST PLACE ARTICLE IN 2021
is presented to
Shannon N. Youngblood
University of Arkansas for Medical Sciences, Little Rock, Arkansas, and Ochsner Medical Center, Baton Rouge, Louisiana
for
Bullying in the Nuclear Medicine Department and During Clinical Nuclear Medicine Education
J Nucl. Med. Technol. 2021; 49:156–163
Editors’ Choice Award
FOR 2ND PLACE ARTICLE IN 2021
is presented to
Kyohei Okuda, Daisuke Hasegawa, Takashi Kamiya, Hajime Ichikawa, Takuro Umeda, Takushi Ohkubo, and Kenta Miwa
Department of Clinical Radiology, Tottori University Hospital, Yonago, Japan
for
Multicenter Study of Quantitative SPECT: Reproducibility of 99mTc Quantitation Using a Conjugated-Gradient Minimization Reconstruction Algorithm
J Nucl. Med. Technol. 2021; 49:138–142
Editors’ Choice Award
FOR 3RD PLACE ARTICLE IN 2021
is presented to
Pietro Paolo de Barros, Tatiane Sabriela Cagol Camozzato, Tiago Jahn, Flávio Augusto Penna Soares, Letícia Machado da Silva, Jacqueline de Aguiar Soares, and Marco Antonio Neiva Koslosky
Federal Institute of Education, Science, and Technology of Santa Catarina–IFSC, Florianópolis, Santa Catarina, Brazil
for
Analysis of Radiometry on Patients Undergoing Radioactive Iodine Therapy
J Nucl. Med. Technol. 2021; 49:75–81
Editors’ Choice Award
FOR BEST CONTINUING EDUCATION ARTICLE IN 2021
is presented to
Julie Bolin
Nuclear Medicine Technology Program, GateWay Community College, Phoenix, Arizona
for
Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies
J Nucl. Med. Technol. 2021; 49:199–208
Editors’ Choice Award
FOR BEST EDUCATORS’ FORUM ARTICLE IN 2021
is presented to
George Patchoros and Grace Wenzler
Department of Engineering, Physics, and Technology, Bronx Community College, Bronx, New York
for
Satisfying Program-Level Outcomes by Integrating Primary Literature into the Online Classroom
J Nucl. Med. Technol. 2021; 49:170–174
2022 Grants and Awards Recipients (funded by the Nihon Medi-Physics)
2022-2024 Wagner-Torizuka Fellowship Program - n/a 2022
2022 Grant Recipients (funded by the SNMMI Value Initiative)
Medical and Science Student Research Grant - Shirley Chen, Junyu Chen, Yuchen Dai, Roberto Fedrigo, Yan Liu, Noah Nigh, Ali Fele Paranj, Divya Ramakrishnan
Co-op Research Grant - David Ng, MD, PhD; Mariam Aboian, MD, PhD; Jeremie Calais, MD; Sandra Castelanos, MD; Rustain Morgan, MD, MS
Radiopharmaceutical Therapy Fellowship - Sophia O'Brien, MD and Ashwin Singh Parihar, MBBS, MD
2022 Grants and Awards Recipients (funded by the PDEF)
PDEF Mickey Williams Minority Scholarship - Fernando Anleu and Shanton Register
PDEF Professional Development Scholarship - Derrick Gillan, ARRT(N)(MR)(CT)PET
2022 Council and Center Awards
Saul Hertz Award - Andrew M. Scott, MD, FRACP, FAANMS
Peter E. Valk, MD Memorial Lecuteship/Award - Johannes Czernin, MD
GCNMC Lifetime Achievement Award - Shankar Vallabhajosula, PhD
GCNMC Lectureship Award - Christopher Palestro, MD, FACNM, FSNMMI
CIC Barry Siegel Lectureship Award - David Schuster, MD, FACR
Tracey Lynn Faber Award - Emilie Roncali, PhD
Edward Hoffman Lecture Award - Margaret Daube-Witherspoon, PhD
Kuhl Lassen Award - Gil Rabinovici, MD
Berson-Yalow Award - Cassis Varlow, BSc
Hermann Blumgart Award - Andrew Einstein, MD, PhD, FACC, FAHA
CVC Outstanding Educator Award - Prem Soman, MD, PhD
AC Lifetime Achievement Award - Virginia Pappas, CAE
AC Distinguished Service Award - Erin Grady, MD, CCD, FACNM
PIC Conway-Treves Award - n/a 2022
Sally W. Schwarz Award - Neil A. Petry, MS, RPh, BCNP, FAPhA